Anavo Therapeutics Appoints Dr. Vincent G. Brichard as Chairman of the Board

LEIDEN, Netherlands–(BUSINESS WIRE)–Anavo Therapeutics, a global leader in unlocking the full therapeutic potential of phosphatase biology, today announced the appointment of Vincent G. Brichard, M.D., Ph.D., as Chairman of its Board of Directors. Dr. Brichard brings nearly four decades of experience from across the life sciences including groundbreaking biomedical research, drug development, venture capital investment and corporate strategy and transactions. His appointment marks an importan

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.